Effects of human T-lymphotropic virus type II on human immunodeficiency virus type 1 phenotypic evolution

Arch Virol. 2001 Aug;146(8):1617-22. doi: 10.1007/s007050170083.

Abstract

Phenotypic change and broader coreceptor usage by HIV-1 have been associated with disease progression. HIV-1 coreceptor usage by primary isolates obtained from HIV-1-infected and HIV-1/HTLV-II-coinfected individuals was determined. HIV-1 was isolated from 15 of 20 HIV-1-infected and 17 of 24 HIV-1/HTLV-II-coinfected individuals. None of the isolates from either the HIV-1-infected or the coinfected group infected CCR5delta32 PBMCs, suggesting that they all were R5-tropic. Further, both spontaneous and PHA-stimulated production of MIP-1beta and RANTES were similar in HIV-1-infected and coinfected individuals. These data indicate that coinfection with HTLV-II has no effect on HIV-1 coreceptor usage or ex vivo beta-chemokine production.

MeSH terms

  • CD4-Positive T-Lymphocytes / virology
  • Chemokines, CC / metabolism
  • Disease Progression
  • HIV Infections / complications*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1 / classification
  • HIV-1 / physiology*
  • HTLV-II Infections / complications*
  • HTLV-II Infections / immunology
  • HTLV-II Infections / virology
  • Human T-lymphotropic virus 2 / physiology*
  • Humans
  • Phenotype
  • Receptors, CCR5 / metabolism

Substances

  • Chemokines, CC
  • Receptors, CCR5